The Pancreatic Society of Great Britain & Ireland.


An alliance of professionals advancing the understanding and management of pancreatic conditions, for the benefit of patients.

(PERT) shortage

Position Statement: Pancreatic enzyme replacement therapy

Make a Donation to PSGBI

Help support our work

Grants and Bursaries

Funding for Member projects

Patients

Information for patients

Access the Journal

Free access for members

Our Mission:


The Pancreatic Society of Great Britain and Ireland will promote, encourage and support study and research into diseases of the pancreas and will actively promote professional discussions and dissemination of knowledge, for the benefit of patients and the public in the United Kingdom and Ireland. We will work to build professional relationships with other national societies throughout the world and support our members through shared learning from these relationships.

History: The first meeting of the Pancreatic Society of Great Britain and Ireland was held on 16 June 1975 at the Royal College of Surgeons of England.Sir Rodney Smith was elected as the first president of the Society and Mr Michael Knight as Secretary and Treasurer. Other officers elected at the meeting included Professor Henry Howat, Professor Patrick Collins, Mr Peter Bevan, Dr Martin Sarner and Mr John Trapnell.

The first presentation was given by Mr C W Imrie. At the first meeting there were sixty-eight participants. Since then the Society has held an annual meeting hosted by the President and regularly attended by over a hundred delegates.

The Pancreatic Society has close links with the British Society of Gastroenterology (BSG), the European Pancreatic Club (EPC) and the International Association of Pancreatology (IAP). The abstracts of the annual meeting of the Society are published in the journal “Pancreatology”.


 

 

News

There are no articles currently

Events

There are no upcoming events.

Pancreatology Journal, latest articles

Letter to the editor regarding “Early detection of pancreatic cancer: Study design and analytical considerations in biomarker discovery and early phase validation studies”

5 Feb 2025, 6 p.m.

Publication date: Available online 27 January 2025Source: PancreatologyAuthor(s): Stuart G. ...

Beyond 4 weeks? Rethinking the timing of LAMS removal in WOPN

5 Feb 2025, 6 p.m.

Publication date: Available online 29 January 2025Source: PancreatologyAuthor(s): Saswati Kar, ...

The efficacy and safety profile of third-line treatment in patients with metastatic pancreatic adenocarcinoma

5 Feb 2025, 6 p.m.

Publication date: Available online 1 February 2025Source: PancreatologyAuthor(s): Chi-Chen Lan, ...

Contrast agent dispersion visualized by CE-EUS may be a prediction tool for FOLFIRINOX chemotherapy effectiveness in patients with pancreatic adenocarcinoma

5 Feb 2025, 6 p.m.

Publication date: Available online 1 February 2025Source: PancreatologyAuthor(s): Mike J.P. ...

Editorial Board

5 Feb 2025, 6 p.m.

Publication date: February 2025Source: Pancreatology, Volume 25, Issue 1Author(s):

WHY IS THE RECTAL ROUTE FOR NSAIDS FAVORABLE FOR PREVENTING POST-ERCP PANCREATITIS?

5 Feb 2025, 6 p.m.

Publication date: Available online 4 February 2025Source: PancreatologyAuthor(s): Gayathri Swaminathan, ...

Albumin Ratio-Based Indicator for Predicting Inpatient Mortality in Acute Pancreatitis Patients Admitted to the Intensive Care Unit

5 Feb 2025, 6 p.m.

Publication date: Available online 4 February 2025Source: PancreatologyAuthor(s): Guangyao Yang, ...

Letter to the editor: Risk score to predict inpatient mortality of acute pancreatitis patients admitted to the intensive care unit

5 Feb 2025, 6 p.m.

Publication date: Available online 4 February 2025Source: PancreatologyAuthor(s): Hiba Thasleem, ...